Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Clinical trial NCT06361030 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06361030
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Cancer Non-resectable Pancreatic Ductal Adenocarcinoma, PDAC

Start date: 2024-06-01
Primary completion: 2026-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.